We studied retrospectively 60 consecutive recipients of an implantable cardioverter-defibrillator and identified 16 patients who were temporarily on and off beta-blockers (further medication unchanged). An intraindividual analysis revealed that 56% of the patients experienced more arrhythmic episodes during follow-up off beta-blockers compared to 44% while being on beta-blockers. Also, the mean episode frequency during follow-up time on and off beta-blockers was comparable (0.4+/-0.6 vs. 0.5+/-0.5, ns).